Related Experiment Video
Updated: Aug 20, 2025
10:56
Combining Human Organoids and Organ-on-a-Chip Technology to Model Intestinal Region-Specific Functionality
Published on: May 5, 2022
13.8K
Modeling Inflammatory Bowel Disease by Intestinal Organoids
Cristina Di Giorgio1, Rosalinda Roselli2, Michele Biagioli1
1Dipartimento di Medicina e Chirurgia, Università di Perugia; Perugia, Italy.
Recent Advances in Inflammation & Allergy Drug Discovery
|November 22, 2022
Summary
Inflammatory bowel disease (IBD) research uses patient organoids to study disease mechanisms. Combining organoids with immune cells and microbiota can improve personalized IBD therapy development.
Area of Science:
- Gastroenterology
- Immunology
- Regenerative Medicine
Background:
- Inflammatory bowel disease (IBD) is a chronic condition with increasing global prevalence.
- Current IBD therapies are suboptimal due to complex and variable disease mechanisms.
- Individualized therapeutic approaches are needed for effective IBD management.
Conclusions:
- Intestinal organoids are valuable tools for IBD research, particularly for personalized therapy.
- Integrating immune components and microbiota into organoid systems is crucial for advancing IBD translational medicine.
- Improved organoid models hold promise for developing targeted and effective IBD treatments.
